Medicare Enrolled
Dr. Hamid Fadavi, D.O.
Pain Medicine (Physical Medicine & Rehabilitation) Physician · Mission Viejo, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Fadavi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Fadavi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Fadavi
Dr. Hamid Fadavi is a pain medicine physician in Mission Viejo, CA, with 16 years of NPI registration. Based on federal Medicare data, Dr. Fadavi performed 16,339 Medicare services across 1,025 unique beneficiaries.
Between the years covered by Open Payments, Dr. Fadavi received a total of $18,500 from 61 pharmaceutical and/or device companies across 700 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine (physical medicine & rehabilitation) physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Fadavi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 4% volume in CA
$18,500 industry payments
Medicare Practice Summary
Medicare Utilization ↗16,339
Medicare services
Top 4% in CA for pain medicine (physical medicine & rehabilitation) physician
1,025
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,021 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
9,500 | $5 | $15 |
| Injection, ropivacaine hydrochloride, 1 mg | 1,857 | $0 | $2 |
| Bupivacaine injection, 0.5 mg An injection of bupivacaine, a local anesthetic, administered in a dose of 0.5 mg. |
1,640 | $0 | $1 |
| Joint lubricant injection (TriVisc) An injection of hyaluronan or a derivative into a joint space. The dose specified is 1 milligram. |
1,150 | $7 | $22 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
636 | $102 | $307 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
259 | $0 | $2 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
211 | $1 | $6 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
171 | $68 | $211 |
| Injection, methylprednisolone acetate, 40 mg | 116 | $6 | $35 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
115 | $50 | $420 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
96 | $100 | $255 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
81 | $93 | $253 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
79 | $0 | $27 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
50 | $85 | $528 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
50 | $47 | $262 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
45 | $128 | $413 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
39 | $49 | $166 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
31 | $90 | $679 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
30 | $168 | $1,238 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
28 | $42 | $277 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
27 | $81 | $619 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
25 | $156 | $539 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
23 | $66 | $170 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
23 | $1 | $5 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
20 | $55 | $692 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
20 | $145 | $375 |
| Methylprednisolone acetate injection, 20 mg A 20 mg injection of methylprednisolone acetate, a corticosteroid medication. This code specifies the drug and dosage administered. |
17 | $3 | $26 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.1% high complexity
93.5% medium
6.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$18,500
Total received (2018-2024)
Avg $2,643/year across 7 years
Top 13% in CA for pain medicine (physical medicine & rehabilitation) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
61
Companies
700
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,989 (70.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,511 (29.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,620
2023
$3,477
2022
$1,632
2021
$2,811
2020
$4,730
2019
$1,542
2018
$1,689
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$690
Boston Scientific Corporation
$548
Medtronic, Inc.
$275
Curonix LLC
$224
TerSera Therapeutics LLC
$115
Collegium Pharmaceutical, Inc.
$103
Merz Pharmaceuticals, LLC
$92
Ipsen Biopharmaceuticals, Inc
$82
Valinor Pharma, LLC
$82
Abbott Laboratories
$72
Nevro Corp.
$51
SCILEX PHARMACEUTICALS INC.
$36
PFIZER INC.
$35
SI-BONE, INC.
$34
Nalu Medical, Inc.
$32
Stryker Corporation
$30
Lundbeck LLC
$28
Azurity Pharmaceuticals, Inc.
$24
DePuy Synthes Sales Inc.
$24
Vertos Medical, Inc.
$22
BIOTISSUE HOLDINGS INC.
$22
Top 3 companies account for 57.7% of 2024 payments
All-time payments by company (2018-2024) ›
Allergan, Inc.
$5,527
ABBVIE INC.
$2,131
Medtronic, Inc.
$1,535
Boston Scientific Corporation
$970
Nevro Corp.
$940
Abbott Laboratories
$820
Curonix LLC
$602
Medtronic USA, Inc.
$484
Collegium Pharmaceutical, Inc.
$480
Allergan Inc.
$451
Merz Pharmaceuticals, LLC
$347
TerSera Therapeutics LLC
$270
Almatica Pharma LLC
$267
Daiichi Sankyo Inc.
$216
Valinor Pharma, LLC
$198
BioDelivery Sciences International, Inc.
$192
Stimwave Technologies Incorporated
$182
BOSTON SCIENTIFIC CORPORATION
$162
SPR Therapeutics, Inc
$141
Merz North America, Inc.
$134
Biohaven Pharmaceutical Holding Company Ltd.
$133
AbbVie Inc.
$130
ARBOR PHARMACEUTICALS, INC.
$119
PFIZER INC.
$116
Egalet US Inc
$114
INSYS Therapeutics Inc
$111
DePuy Synthes Sales Inc.
$105
Scilex Pharmaceuticals Inc.
$101
Indivior Inc.
$100
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$93
SCILEX PHARMACEUTICALS INC.
$90
Biohaven Pharmaceuticals, Inc.
$84
Novartis Pharmaceuticals Corporation
$84
Ipsen Biopharmaceuticals, Inc
$82
Jazz Pharmaceuticals Inc.
$81
Azurity Pharmaceuticals, Inc.
$68
Relievant Medsystems, Inc.
$67
West Therapeutics Development, LLC
$64
Lilly USA, LLC
$64
Sentynl Therapeutics, Inc.
$56
Assertio Therapeutics, Inc.
$56
US WorldMeds, LLC
$54
Zyla Life Sciences
$52
IMPEL PHARMACEUTICALS INC.
$45
SI-BONE, INC.
$34
Nalu Medical, Inc.
$32
Iroko Pharmaceuticals, LLC
$30
Stryker Corporation
$30
Lundbeck LLC
$28
MERZ NORTH AMERICA, INC.
$26
AstraZeneca Pharmaceuticals LP
$24
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$24
Vertos Medical, Inc.
$22
BIOTISSUE HOLDINGS INC.
$22
ASSERTIO THERAPEUTICS, INC.
$20
Horizon Therapeutics plc
$19
RedHill Biopharma Inc.
$16
ASSERTIO THERAPEUTICS, Inc.
$15
IBSA Pharma Inc.
$14
Arbor Pharmaceuticals, Inc.
$13
Purdue Pharma L.P.
$11
Top 3 companies account for 49.7% of all-time payments
Associated products mentioned in payments ›
ACCUGUIDE · AIMOVIG · Accurian · BELBUCA · BOTOX · BOTOX COSMETIC · BOTOX THERAPEUTIC · BUNAVAIL 2.1 mg 30-count box · Belbuca · CFNS StimQ Peripheral Nerve StimulatorSystem · COMIRNATY · Cambia · Dysport · EMGALITY · Edarbi · GENERAL PAIN MANAGEMENT · GENERAL - PAIN MANAGEMENT · GRALISE · Gralise · HORIZANT · Horizant · INTELLIS · INTELLIS ADAPTIVESTIM · Intracept · LICART · LUCEMYRA · Levorphanol · Lucemyra/Lofexidine · MILD DEVICE KIT · MONOVISC · MOVANTIK · Morphabond ER · Movantik · N'VISION · NAPRELAN · NURTEC ODT · Nalu Neurostimulation System · Omnia · PAXLOVID · PENNSAID · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PRIALT · PROCLAIM · Prialt · Proclaim Family of SCS IPGs · Proclaim IPG · Protege Family of SCS IPGs · QULIPTA · RELISTOR · RELISTOR ORAL · RESTORE · SPECTRA WAVEWRITER · SPRINT PNS System · SPRIX · SUBLOCADE · SUBOXONE SUBLINGUAL FILM · SUBSYS · SYMPROIC · SYNCHROMEDII · SYNDROS · Senza · Senza Spinal Cord Stimulation System · StimQ Receiver Stimulator Kit Channel A US w Receiver · StimQ Receiver Stimulator Kit Channel A US w/Receiver · Subsys · Superion · Trudhesa · UBRELVY · VECTRIS · VIVLODEX · VYEPTI · Vanta · WaveWriter Alpha Prime 16 · XEOMIN · XTAMPZA · Xeomin · ZORVOLEX · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (70%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pain medicine physicians within 10 mi
30
Per 100K population
0.9
County median income
$113,702
Nearest hospital
PROVIDENCE MISSION HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Fadavi is a mixed practice specialist, with above-average Medicare volume (top 4% in CA), with low-engagement industry engagement in the top 13% of CA peers, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Fadavi experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Fadavi performed 9,500 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Fadavi receive payments from pharmaceutical companies?
Yes. Dr. Fadavi received a total of $18,500 from 61 companies across 700 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Fadavi's costs compare to other pain medicine physicians in Mission Viejo?
Dr. Fadavi's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Fadavi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Pain Medicine Physicians in Mission Viejo
Browse pain medicine physicians in Mission Viejo ranked by procedure volume and transparency data.
Highest volume
Top Pain Medicine Physicians in CA
Pain medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pain Medicine Physicians in CA
Which CA pain medicine physicians receive the most from drug and device companies.
By company
Allergan, Inc. Payments to Doctors
See all physicians who received payments from Allergan, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology